Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1 by Sakaue, Yuri et al.
© 2010 Sakaue et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2010:5 687–695
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
687
OrIgINAL reSeArch
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/IJN.S12439
effects of TAT-conjugated platinum nanoparticles 
on lifespan of mitochondrial electron transport 
complex I-deficient Caenorhabditis elegans, nuo-1
Yuri Sakaue
Juewon Kim
Yusei Miyamoto
Department of Integrated  
Biosciences, University of Tokyo, 
chiba, Japan
correspondence: Yusei Miyamoto 
Department of Integrated Biosciences, 
graduate School of Frontier Sciences, 
University of Tokyo, Bioscience Building 
402, 5-1-5 Kashiwanoha, Kashiwa, chiba 
277–8562, Japan 
Tel +81 471 36 3628 
Fax +81 471 36 3630 
email yusei74@k.u-tokyo.ac.jp
Abstract: Platinum nanoparticle (Pt-np) species are superoxide dismutase/catalase mimetics 
and also have an activity similar to that of mitochondrial electron transport complex I. To examine 
if this complex I-like activity functions in vivo, we studied the effects of Pt-nps on the lifespan 
of a mitochondrial complex I-deficient Caenorhabditis elegans mutant, nuo-1 (LB25) com-
pared with wild-type N2. We synthesized a fusion protein of a cell-penetrating peptide, human 
immunodeficiency virus-1 TAT (48–60), C-terminally linked to a peptide with a high affinity 
to platinum (GRKKRRQRRRPPQ-DRTSTWR). Pt-nps were functionalized by conjugation 
with this fusion protein at a 1:1 ratio of TAT-PtBP to Pt atoms. Adult worms were treated with 
conjugated Pt-nps for 10 days. The mean lifespan of untreated N2 and LB25 was 19.6 ± 0.4 and 
11.8 ± 0.3 days, respectively. Using 5 µM of conjugated Pt-nps, the lifespan of N2 and LB25 
was maximally extended. This maximal lifespan extension of LB25 was 31.9 ± 2.6%, which was 
significantly greater than that of N2 (21.1 ± 1.7%, P , 0.05 by Student’s t-test). Internalization 
of Pt into the whole body and mitochondria was similar between these two strains. Excessive 
accumulation of reactive oxygen species was not observed in the cytosol or mitochondria of 
untreated LB25. Treatment for five days with 5 µM conjugated Pt-nps decreased cytosolic and 
mitochondrial reactive oxygen species in N2 and LB25 to a similar extent. The ratio of [NAD+]/
[NADH] was very low in the whole body and mitochondria of control LB25. After five days 
of treatment with 5 µM conjugated Pt-nps, the ratio of [NAD+]/[NADH] was increased in N2 
and LB25. However, the degree of the increase was much higher in LB25 than in N2. Pt-nps 
function as NADH oxidase and recover the [NAD+]/[NADH] ratio in LB25, leading to effective 
extension of the lifespan of LB25.
Keywords: platinum nanoparticles, Caenorhabditis elegans, complex I-deficient mutant, 
LB25, lifespan
Introduction
Platinum nanoparticles (Pt-nps) are an efficient catalyst for electro-oxidation of 
hydrogen peroxide (H2O2).1 Owing to this catalase activity, Pt-nps are utilized 
as a fine   element of biosensors.2,3 However, Pt-nps have not been developed suf-
ficient for biologic or medical use compared with gold nanoparticles (Au-nps).4–6 
Recently, some papers have shown biologic and medical application of Pt-nps, 
including usage as a platform for drug delivery.7–9 We regard Pt-nps as a bioactive 
material, ie, a kind of antioxidant, and have undertaken research on these entities. 
In vitro Pt-nps scavenge reactive oxygen species (ROS) including superoxide anion 
(O2
−) as well as H2O2, and free radicals.1,10 Pt-nps seem to have catalytic antioxi-
dant activity. Because the   O2
−-scavenging activity of Au-nps is less than that of International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Pt-nps, and Au-nps cannot scavenge H2O2, Pt-nps are a 
more potent antioxidant than Au-nps.1 In vivo we tested 
the effects of Pt-nps on the lifespan of Caenorhabditis 
elegans.11 Pt-nps extended the lifespan of wild-type N2 and 
the mitochondrial electron transport complex II mutant, 
mev-1(kn1), whereas a well known superoxide dismutase/
catalase mimetic, EUK-8, did not do this. Furthermore, 
  Pt-nps exhibited more effective   protection of nematodes 
against acute oxidative stress induced by paraquat than 
EUK-8. These data suggest that Pt-nps scavenge exces-
sive oxidative stress to elongate the lifespan and survival 
of nematodes.
Mitochondrial electron transport complex I consists 
of many subunits and is located in the mitochondrial 
inner membrane.12 This complex is NADH:ubiquinone 
oxidoreductase that transfers electrons from NADH in the 
matrix to ubiquinone in the inner membrane, with proton 
transport from the matrix to the mitochondrial intramem-
brane space. In some diseases the complex I is deficient 
or its enzymatic activity is suppressed, leading to genera-
tion of an excessive amount of O2
−. Accumulated ROS 
seem to contribute partially to the pathogenesis of those 
diseases.13–16 Recently, we have shown in vitro that Pt-nps 
have an activity similar to the complex I that drives oxida-
tion of NADH to NAD+, as well as reduction of ubiquinone 
to ubiqunol.17 Although it is still not known if Pt-nps 
transport protons, we expect that Pt-np species will be an 
enzymatic mimetic of mitochondrial complex I.   Pt-nps 
are able to mediate oxidation of NADH and   reduction 
of ubiquinone separately. In other words, Pt-nps do not 
require electrons from NADH to reduce ubiquinone. We 
suspect that Pt-nps may accept and release electrons by 
interaction with water molecules.
A mitochondrial complex I-deficient C. elegans 
mutant, LB25, is a transgenic strain expressing the nuo-1 
(NADH:ubiquinone oxidoreductase) gene carrying an 
A352V mutation.18 The nuo-1 gene is the C. elegans 
homolog of the human NDUFV1 (NADH dehydrogenase 
ubiquinone flavoprotein 1) gene encoding the active site 
subunit of complex I. The A352V mutation corresponds 
to the residue A341 of the human NDUFV1 gene which 
causes severe neurologic disorders and muscle atrophy in 
early childhood.13 In this study, we describe the significance 
of Pt-nps as a mitochondrial complex I mimetic, as well as 
an antioxidant, in partial recovery of the short lifespan of 
LB25, indicating that Pt-np species may be a new potent 
material for diseases with dysfunctional mitochondrial 
complex I.
Material and methods
C. elegans and growth conditions
Wild-type N2 and a mitochondrial complex I-deficient 
mutant C. elegans, nuo-1 (LB25), were obtained from the 
Caenorhabditis Genetic Center (University of Minnesota, 
St Paul, MN). These strains were maintained at 20°C by a 
  popular procedure established by Brenner.19 Age-  synchronous 
populations were prepared as previously described.11 Briefly, 
collected eggs were allowed to hatch overnight at 20°C in 
1 mL of S-basal buffer (100 mM NaCl, 0.01 mM cholesterol, 
and 50 mM potassium phosphate, pH 6.0), on nematode 
growth medium agar plates.20 Hatched worms (L1 larval 
stage) were transferred to fresh nematode growth medium 
agar plates with Escherichia coli OP50 as a food source, and 
cultured at 20°C until the L4 larval stage.
Preparation of Pt-nps
Pt-nps were prepared by an ethanol reduction method of hydro-
gen hexachloroplatinate (H2PtCl6) using poly(N-vinyl-2-pyr-
rolidone, PVP) as a protecting reagent.11 PVP, H2PtCl6⋅6H2O, 
and ethanol were purchased from Wako Pure Chemical 
Industries (Osaka, Japan). Water was freshly prepared with a 
Millipore Milli-Q Academic Water Purification System (Mil-
lipore, Billerica, MA). We estimated the concentration of Pt in 
Pt-nps from the concentration of PtCl6
2− in a starting reaction 
mixture, assuming 100% reduction of Pt4+ to Pt. Therefore, 
the Pt-nps concentrations reported herein actually refer to the 
estimated concentration of Pt atoms present in Pt-nps.
The human immunodeficiency virus (HIV)-1 protein, 
TAT, is a transcriptional activator of HIV . TAT consists of 
86 amino acids, but its translocation activity is associated 
with the peptide sequence (48–60; GRKKRRQRRRPPQ).21 
A short peptide (DRTSTWR) is known to be one with high 
affinity to platinum and is referred to here as a platinum-
binding peptide (PtBP).22 A fusion peptide was synthesized 
by C-terminally linking of HIV-1 TAT (48–60) to PtBP 
(GRKKRRQRRRPPQ-DRTSTWR). Pt-nps protected with 
PVP (PVP-Pt) were conjugated with this fusion protein 
(TAT-PtBP) at a 1:1 ratio of TAT-PtBP to Pt atom to increase 
the internalization of Pt-nps into worms.23 The consequent 
conjugate was designated as TAT-PtBP-Pt. Therefore, 
unconjugated Pt-nps indicates PVP-Pt.
Lifespan assay
For the lifespan assay, synchronous L4 larvae were transferred 
to S-medium (S-basal medium supplemented with 3 mM 
CaCl2, 3 mM MgSO4, 50 µM ethylenediamine   tetraacetic International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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acid [EDTA], 25 µM FeSO4, 10 µM MnCl2, 10 µM ZnSO4, 
1 µM CuSO4, and 10 mM KH2PO4, at pH 6.0) with E. coli 
OP50.24 We chose a liquid medium because it was difficult 
to make an agar plate in which TAT-PtBP-Pt were evenly 
distributed and, furthermore, because worms were allowed 
to make contact freely with TAT-PtBP-Pt. This transfer day 
was recorded as Day 0. Nematodes were treated with TAT-
PtBP-Pt for 10 days from Day 0. The worms were transferred 
to fresh culture medium every second day, and the surviv-
ing worms were counted at the same time. Worms that died 
unnaturally were excluded. The mortality data were subjected 
to Kaplan–Meier survival analysis to prepare survival curves. 
Statistical comparisons of mean lifespan values between 
untreated (control) and treated worms were analyzed by 
Peto’s log-rank test.
Isolation of mitochondria
Isolation of mitochondria was performed as previously 
described.18 Worms were collected from liquid culture and 
rinsed three times with M9 buffer (3 g/L KH2PO4, 6 g/L 
Na2HPO4, and 5 g/L NaCl supplemented with 1 mM MgSO4 
and 0.02% gelatin after autoclaving). Rinsed worms were sus-
pended in 0.2 M mannitol, 70 mM sucrose, 0.1 M EDTA, and 
1 mM phenylmethylsulfonyl fluoride at pH 7.4. Worms were 
homogenized 10 times by a BRANSON   Sonifier 150 with 
a 3 mm diameter probe (Branson Ultrasonic Co.,   Danbury, 
CT). Homogenized samples were centrifuged three times 
at 1000 × g for 10 minutes to eliminate unbroken cells and 
cuticles. The supernatant was then centrifuged at 19,200 × g 
for 10 minutes to precipitate mitochondria. The pellet was 
suspended in 0.2 M mannitol, 70 mM sucrose, and 0.1 M 
EDTA, pH 7.4 (MSE buffer) and centrifuged again. The 
resultant sediment containing mitochondria was resuspended 
in 0.5 mL MSE buffer. Protein concentration was estimated 
by the Bradford method with a commercially available kit 
(Bio-Rad, Hercules, CA).
Measurement of platinum content
On Day 0, treatments of N2 and LB25 with 5 µM   TAT-PtBP-Pt 
were started and continued for five days.   Nematodes treated 
with unconjugated PVP-Pt served as controls. Treated nema-
todes were rinsed three times with M9 buffer and transferred 
to crucibles with 1 mL of 1% nitric acid, 60% perchloric acid, 
and 35% chloric acid.23 The samples ware heated and volatil-
ized at 200°C using an   electric hot plate, followed by heating 
with 1 mL of 1% nitric acid three times. Finally, the samples 
were   resuspended in 5 mL of 1% nitric acid. Determination 
of amount of Pt in the   resuspended samples was performed. 
Measurements of Pt internalized in mitochondria were 
  performed using similar procedures. The statistical significance 
of differences between the control and treated groups was 
determined by Student’s t-test.
Measurement of reactive oxygen species
N2 and LB25 nematodes were treated with 5 µM  TAT-
PtBP-Pt for five days from Day 0. On day 5, the treated 
nematodes were washed three times with M9 buffer. The 
worms were then incubated for 30 minutes at 20°C in 
2 mL of Hank’s solution (0.44 mM KH2PO4, 5.37 mM 
KCl, 0.34 mM Na2HPO4, 136.89 mM NaCl, and 5.55 mM 
D-glucose) containing 10 µM 5-(and 6)-chloromethyl-
2’,7’-dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA) (Sigma-Aldrich Co., St. Louis, MO) and/
or MitoSOX™ Red (MitoSox, obtained from Invitrogen, 
Carlsbad, CA).11 CM-H2DCF released by esterase and Mito-
Sox were fluorescent dyes to assay cytosolic ROS mainly 
consisting of H2O2 and mitochondrial O2
−, respectively. 
Worms were fixed with 4% formaldehyde and mounted on 
2% agarose pads. To determine the fluorescence of CM-
H2DCF and MitoSOX, fixed nematode samples were sub-
jected to Leica TCS SP2 laser scanning confocal microscopy 
(CM-H2DCF, excitation at 488 nm and emission at 510 nm; 
MitoSOX, excitation at 510 nm and emission at 580 nm). 
The relative fluorescence of the whole body was determined 
densitometrically using the LCS Lite software. The statis-
tical significance of differences between the control and 
treated groups was determined by Student’s t-test.
NAD+ and NADh assays
Nematodes were treated with 5 µM TAT-PtBP-Pt for five days 
from Day 0. On Day 5, treated animals were rinsed three 
times with M9 buffer. Rinsed worms were suspended in 
100 mM NaCl, 1% NP-40, 1 mM DTT, 10% glycerol, and 
100 mM Tris, at pH 8. Worms were homogenized 10 times 
by BRANSON Sonifier 150 with a 3 mm diameter probe. 
Protein concentration was estimated by the Bradford method. 
We used an NAD+/NADH assay kit (Gentaur, Kampenhout, 
Belgium). Homogenized samples were mixed with 100 µL 
of NAD+ extraction buffer for NAD+ estimation or NADH 
extraction buffer for NADH estimation and heated at 60°C for 
five minutes. Twenty microliters of assay buffer and 100 µL 
of NADH (or NAD+) extraction buffer were added. Samples 
were then vortexed and spun at 10,000 × rpm for five minutes. 
The resultant supernatant was used for NAD+ and NADH 
assays. Similar procedures were performed to determine 
NAD+ and NADH in isolated mitochondria. The statistical International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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significance of differences between the control and treated 
groups was determined by Student’s t-test.
Results and discussion
TAT-PtBP-Pt extends lifespan of wild-type 
N2 and nuo-1 mutant
The survival of control wild-type N2 and mutant LB25 
delineates regular reverse-sigmoid curves (Figure 1A). The 
mutants died earlier than the wild type. Treatment with 5 µM 
TAT-PtBP-Pt for 10 days from Day 0 shifts the survival 
curves of N2 and LB25 to the right, indicating extension of 
their lifespan. The mean lifespan was obtained by calculat-
ing the data of the survival curves. The mean lifespans of 
control N2 and LB25 were 19.6 ± 0.4 and 11.8 ± 0.3 days, 
respectively, indicating that the mean lifespan of LB25 is 
approximately 40% less than that of N2 (see Table). This 
result is in good accordance with a previous report.18 The 
concentration of TAT-PtBP-Pt was varied from 1–25 µM. 
While the lifespan of N2 was significantly extended by TAT-
PtBP-Pt only at 5 µM (***P , 0.001), the mutant lifespan 
was extended by more than 5 µM and was maximal at 5 µM 
(**P , 0.01 (10 and 25 µM), ***P , 0.001 (5 µM), as 
shown in Figure 1B and Table 1). The maximal lifespan of 
LB25 was 15.6 ± 0.4 days by 31.9 ± 2.6% increase of their 
control lifespan (see Table 1). Treatment of N2 with 5 µM 
TAT-PtBP-Pt extended the mean lifespan to 23.3 ± 0.4 days 
only by 21.1 ± 1.7%. TAT-PtBP at 25 µM alone did not affect 
either N2 or LB25 lifespan (Figure 1B and Table 1). These 
data suggest that Pt in TAT-PtBP-Pt is the active source of 
the nematode lifespan extension, and the lifespan extension 
by Pt-nps is significantly more effective in LB25 than in N2 
(P , 0.05 by Student’s t-test).
Recently, we have performed a similar experiment to 
monitor the lifespan extension of wild-type nematode N2 
by conjugation of Pt-nps with TAT-PTBP.23 The lifespan of 
control N2 was 18.0 ± 0.3 days. Treatment with TAT-PtBP-Pt 
significantly elongated the lifespan in the concentration range 
1–50 µM (P , 0.001). The maximal extension of lifespan 
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was observed with 5 µM TAT-PtBP-Pt. The maximal mean 
lifespan was 22.4 ± 0.4 days, resulting in an increase of 24%. 
The experimental difference between our previous and cur-
rent studies is the treatment period. Nematodes were treated 
until death in the previous study, but only for 10 days in the 
current study.
The optimal increase of life span by TAT-PtBP-Pt was 
observed at 5 µM. Greater concentrations of TAT-PtBP-Pt 
showed less positive effects. Currently, we do not have a clear 
explanation for this phenomenon. A possible speculation is 
that the lifespan extension by Pt-nps may gradually decrease 
with the concentration increase due to toxicity. Pt-nps may 
extend lifespan by activating cellular signaling via a small 
change of ROS, but not by a big change.25 Further studies 
are required.
Similar internalization of Pt-nps  
by N2 and nuo-1
The amount of Pt internalized in N2 and LB25 whole bod-
ies by treatment with 5 µM unconjugated PVP-Pt for five 
days from Day 0 was 3.30 ± 0.05 and 3.33 ± 0.12 ng/worm, 
  respectively (Figure 2A). Conjugation of Pt-nps with 
TAT-PtBP enhances Pt internalization approximately 
six times in both nematodes (***P , 0.001; amount of 
internalized Pt in N2 and LB25 whole bodies, 19.9 ± 0.4 
and 21.3 ± 0.9 ng/worm, respectively). The mitochon-
drial Pt   accumulation from PVP-Pt was approximately 
1% of the whole body Pt accumulation (29.1 ± 0.8 and 
22.7 ± 0.3 pg/worm in N2 and LB25   mitochondria, 
  respectively, Figure 2B). Although TAT was used as a 
cell-penetrating peptide (CPP), it was significantly effective 
even in mitochondrial translocation (***P , 0.001; N2 and 
LB25, 55.3 ± 2.0 and 55.7 ± 0.3 ng/worm, respectively). 
There was not a significant difference in whole body or 
mitochondrial accumulation of Pt from TAT-PtBP-Pt 
between these two strains. Therefore, the more effective 
lifespan extension of LB25 than N2 by treatment with 5 µM 
TAT-PtBP-Pt is not due to the higher permeability of Pt in 
LB25 than N2.
CPPs are referred to as protein transduction domains and 
utilized to facilitate cellular uptake of hydrophilic bioactive 
large molecules.26 TAT is one of the popular CPPs and suc-
cessful in delivery of proteins, peptides, and nucleotides 
across the cell membrane.27 TAT has been used for protein 
delivery, even in C. elegans.28 CPPs are usually linked to 
cargoes by covalent binding.29 For example, in the case of 
Au-nps, tiopronin, a kind of spacer, was first covalently 
bound to gold atoms via a sulfhydryl group during reduc-
tion of AuCl4
− by NaBH4.30 TAT was then covalently bound 
to tiopronin to functionalize the Au-nps. We used PtBP to 
link TAT to Pt-nps.23 This is a unique approach to transcel-
lular delivery of metal-nps. Although precise mechanisms 
for internalization of Pt-nps into nematodes are unknown, 
we assume that intestinal permeability of Pt-nps is enhanced 
by conjugation with TAT-PtBP. Previous studies have shown 
that TAT conjugation leads Au-nps to nuclear translocation 
in cells.30,31 Furthermore, CPPs interrupt mitochondrial 
targetting.32 Our results indicate that TAT-PtBP conjugation 
facilitates mitochondrial translocation of Pt-nps to a small 
but significant extent. We need more sophisticated research 
on intracellular localization of TAT conjugated Pt-nps.
reactive oxygen species in cytosol  
and mitochondria of N2 and nuo-1
The effects of TAT-PtBP-Pt treatment on ROS were investi-
gated in N2 and LB25. Typical fluorescence from cytosolic 
CM-H2DCF in the whole body is shown in Figure 3A–D (A, 
control N2; B, treated N2; C, control LB25; D, treated LB25). 
The fluorescent intensity obtained using LCS Lite software 
was similar between control N2 and LB25 (46.4 ± 2.8 and 
42.5 ± 2.8, respectively). The relative fluorescence is shown 
in Figure 3E. Treatment with 5 µM TAT-PtBP-Pt for five 
days from Day 0 significantly decreased the fluorescence, and 
the extent of this reduction was also similar between these 
two strains (−39.2 ± 2.1 and −33.7 ± 1.8%, respectively, 
*P , 0.05). Mitochondrial O2
− was also measured with 
MitoSox in Figure 4A–D; A, control N2; B, treated N2; C, 
control LB25; D, treated LB25). The fluorescent intensity 
Table 1 effects of TAT-PtBP-Pt on the lifespan of C. elegans
Strain Treatment μM MLS % P n
N2 control 0 19.6 ± 0.4 91
TAT-PtBP-Pt 1 19.5 ± 0.4 −0.2 ± 2.0 0.628 90
2.5 19.9 ± 0.4   1.9 ± 1.7 0.447 90
5 23.3 ± 0.4 21.1 ± 2.0 3.04e-7 90
10 20.9 ± 0.4   6.8 ± 1.9 0.171 90
25 19.3 ± 0.4 −1.5 ± 2.1 0.462 90
TAT-PfBP 25 19.3 ± 0.4     0 ± 2.1 0.575 90
LB25 control 0 11.8 ± 0.3 93
TAT-PtBP-Pt 1 12.0 ± 0.3   2.0 ± 2.5 0.754 90
2.5 12.2 ± 0.3   3.4 ± 2.5 0.684 90
5 15.6 ± 0.4 31.9 ± 2.6 2.73e-4 95
10 14.0 ± 0.3 18.9 ± 3.6 1.39e-3 95
25 13.5 ± 0.4 14.1 ± 3.0 9.36e-3 95
TAT-PtBP 25 11.9 ± 0.3   0.6 ± 2.5 0.887 90
Notes: MLS, mean lifespan (days) presented as mean ± SeM; %, change in MLS 
compared with control, presented as mean ± SeM. 
Abbreviations: SeM, standard error of the mean; MLS, mean lifespan; n, number 
of deaths observed.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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from mitochondrial MitoSox was 48.0 ± 3.0 and 45.7 ± 2.8 in 
control N2 and LB25, respectively (Figure 4E depicted 
with relative fluorescence). A similar treatment with 5 µM 
TAT-PtBP-Pt significantly decreased the MitoSox fluores-
cence (39.6 ± 2.7; *P , 0.05 and 35.9 ± 2.0; **P , 0.01 as 
intensity in N2 and LB25, respectively). These results show 
that ROS accumulation in control LB25 is not excessive, and 
TAT-PtBP-Pt treatment decreases ROS in N2 and LB25 to 
a similar extent. A main cause of the short life of LB25 may 
not be ROS accumulation.
We measured cytosolic and mitochondrial ROS in LB25 
for the first time. Excessive accumulation of ROS was not 
observed in the cytosol or mitochondria of control LB25 in 
comparison with control N2. We think that the quantification 
of ROS level is insufficient due to the ROS estimation by 
fluorescent dyes. However, these results are still interesting. 
It has been reported that 1-methyl-4-phenylpyridinium and 
rotenone, inhibitors of complex I, lead to NADH-dependent 
generation of O2
− using prepared bovine mitochondrial parti-
cles.33 However, this increase of O2
− generation by the inhibi-
tors was measured for a short period. Thus, we have to study 
the perturbation of ROS level by suppression of complex I for 
a long time in vivo. In fact, oxygen consumption was reduced 
by 50% in LB25, compared with N2.18 Decreased oxygen 
consumption is supposed to help decrease the generation of 
ROS. Currently, we do not know how LB25 worms maintain 
ROS at a relatively normal level during life. Because the 
0
10
20
30
40
50
60
70
I
n
t
e
r
n
a
l
i
z
e
d
 
P
t
 
(
n
g
 
p
e
r
 
w
o
r
m
)
0
5
10
15
20
25
A
*** ***
unconjugated
nano-Pt
TAT-
PtBP-Pt
unconjugated
nano-Pt
TAT-
PtBP-Pt
unconjugated
nano-Pt
TAT-
PtBP-Pt
unconjugated
nano-Pt
TAT-
PtBP-Pt
N2 LB25
B
I
n
t
e
r
n
a
l
i
z
e
d
 
P
t
 
(
p
g
 
p
e
r
 
w
o
r
m
)
*** ***
N2 LB25
Figure 2 Amount of Pt internalized in whole bodies and mitochondria of N2 and 
LB25. Animals were treated with 5 µM TAT-PtBP-Pt for five days from Day 0. Pt 
accumulation in worm whole bodies A) and mitochondria B) was determined by an 
inductively-coupled plasma mass spectrometer IcP-MS. For control, unconjugated 
Pt-nps (PVP-Pt) was used. The number of worms used was 100 and 500–508 in 
each  measurement  for  whole  bodies  and  mitochondria,  respectively,  and  three 
independent experiments were repeated. error bars represent the standard error 
of the mean. 
Note: Statistical significance was determined by Student’s t-test (***P , 0.001).
D
A
B
C
R
e
l
a
t
i
v
e
 
f
l
u
o
r
e
s
c
e
n
c
e
1.5
1
0.5
0
* **
E
Control TAT-
PtBP-Pt
Control TAT-
PtBP-Pt
N2 LB25
LB25 N2
Figure 3 effects of TAT-PtBP-Pt on cytosolic reactive oxygen species in N2 and LB25. 
Animals were treated with 5 µM TAT-PtBP-Pt for five days from Day 0. Worms were 
then treated with 10 µM cM-h2DcFDA for 30 minutes at 20°c. Fluorescence was 
measured by confocal florescence microscopy (Ex 488 nm and Em 510 nm). Shown 
is cytosolic reactive oxygen species in N2 and LB-25 whole bodies: A) control N2; 
B) treated N2; C) control LB25; D) treated LB25. The panel E) shows the average 
of relative intensity for three independent experiments with 10 worms per each 
experiment. error bars represent the standard error of the mean. 
Notes: *P , 0.05; **P , 0.01, as compared with control worms by Student’s 
t-test.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
693
Lifespan extension of nuo-1 by Pt-nps
oxidative state must be high in LB25, oxidized substances 
may be accumulated to reduce free ROS. Oxidative marker 
assays will be required.
Increase of [NAD+]/[NADh] ratio  
in nuo-1 by TAT-PtBP-Pt
We measured NAD+ and NADH levels in the whole body 
homogenate and mitochondrial fraction from N2 and LB25. 
The [NAD+]/[NADH] ratio was considerably smaller in the 
whole body (0.057 ± 0.004) and mitochondria (0.026 ± 0.005) 
of control LB25 than in those of control N2 (whole body, 
0.167 ± 0.005; mitochondria, 0.146 ± 0.006), indicating 
excessive accumulation of NADH in LB25 (Figure 5). 
Treatment of N2 with 5 µM TAT-PtBP-Pt significantly 
increased the [NAD+]/[NADH] ratio by approximately 
twice (***P , 0.001). A similar treatment of LB25 with 
5 µM TAT-PtBP-Pt greatly increased the [NAD+]/[NADH] 
ratio by 4.6 and 8.8 times in whole body and mitochondria, 
respectively (***P , 0.001). These results indicate that 
  Pt-nps function as NADH oxidase in C. elegans, and accu-
mulated NADH in LB25 is efficiently oxidized to NAD+. 
This recovery of the [NAD+]/[NADH] ratio may take part 
in the effective lifespan extension of LB25.
In nuo-1 mutants, including LB25, excessive cellular 
NADH caused reduction of pyruvate to lactate.18 Depletion 
of pyruvate slows down tricarboxylic acid cycle and oxida-
tive phosphorylation. We believe that Pt-nps oxidize NADH 
to NAD+ to normalize the NAD+/NADH ratio, which recovers 
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these metabolic pathways and increases adenosine triphosphate 
synthesis, even though the activity of complex IV is decreased 
by approximately 50%.18 Increase of adenosine triphosphate 
helps recover the short life of LB25. One may think that 
accelerated oxidative phosphorylation may produce O2
− as 
a byproduct because LB25 has the low activity of complex 
I. Pt-nps are able to scavenge ROS including O2
−. A similar 
decrease of ROS by TAT-PtBP-Pt treatment was observed 
in the cytosol and mitochondria of N2 and LB25 (Figures 3 
and 4). However, if Pt-nps efficiently scavenge more ROS in 
treated LB25, a similar decrease of ROS may be apparent. The 
lifespan recovery of LB25 by Pt-nps may be supported by the 
maintenance of ROS using Pt-nps. We believe that the NADH 
oxidase activity of Pt-nps in scavenging ROS plays a pivotal 
role in effective recovery of the short lifespan of LB25.
Furthermore, even in wild-type N2, the [NAD+]/[NADH] 
ratio was increased by treatment with Pt-nps. The NAD+-
dependent SIR-2.1 pathway may be involved in the lifespan 
extension caused by treatment with Pt-nps.34 If it is, this signal 
pathway seems to be more effective in LB25 to elongate the 
lifespan because of a marked increase of NAD+ by Pt-nps 
treatment.
Conclusion
Pt-nps functionalized with a TAT fusion protein are internal-
ized in the mitochondria as well as in the cytosol and exert 
NADH oxidase activity. Therefore, Pt-np species may be 
a potent medicinal material to improve symptoms caused 
by mitochondrial complex I defect. Active targeting of 
the Pt-nps to mitochondrial matrix and/or inner membrane 
using signal peptides will be helpful to develop this potency 
further.
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